August J. Troendle, the President & CEO of $MEDP, sold 673 shares of the company on 08-25-2026 for an estimated $417,515. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 544,544 shares of this class of $MEDP stock.
$MEDP Insider Trading Activity
$MEDP insiders have traded $MEDP stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- AUGUST J. TROENDLE (President & CEO) has made 0 purchases and 12 sales selling 105,640 shares for an estimated $64,590,945.
- JESSE J GEIGER (President) sold 31,707 shares for an estimated $14,436,197
- STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 16,349 shares for an estimated $7,357,050
- SUSAN E BURWIG (Exec. VP, Operations) sold 7,500 shares for an estimated $4,500,000
- FRED B JR DAVENPORT sold 7,283 shares for an estimated $4,414,590
- BRIAN T CARLEY sold 5,000 shares for an estimated $3,043,150
- KEVIN M. BRADY (CFO & Treasurer) sold 3,400 shares for an estimated $2,125,816
- CORNELIUS P. III MCCARTHY has made 0 purchases and 2 sales selling 1,935 shares for an estimated $1,155,253.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MEDP Hedge Fund Activity
We have seen 278 institutional investors add shares of $MEDP stock to their portfolio, and 511 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,780,170 shares (+614.9%) to their portfolio in Q2 2026, for an estimated $942,760,230
- D. E. SHAW & CO., INC. removed 293,695 shares (-55.6%) from their portfolio in Q2 2026, for an estimated $155,537,935
- JPMORGAN CHASE & CO added 214,912 shares (+inf%) to their portfolio in Q2 2026, for an estimated $113,815,246
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 211,847 shares (+inf%) to their portfolio in Q2 2026, for an estimated $112,192,052
- MAWER INVESTMENT MANAGEMENT LTD. removed 178,929 shares (-40.1%) from their portfolio in Q2 2026, for an estimated $94,759,009
- FINDLAY PARK PARTNERS LLP removed 174,400 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $83,745,136
- TWO SIGMA INVESTMENTS, LP removed 166,817 shares (-94.5%) from their portfolio in Q2 2026, for an estimated $88,344,615
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MEDP Revenue
$MEDP had revenues of $707.3M in Q2 2026. This is an increase of 17.24% from the same period in the prior year.
You can track MEDP financials on Quiver Quantitative's MEDP stock page.
You can access data on MEDP stock through the Quiver Quantitative API.
$MEDP Congressional Stock Trading
Members of Congress have traded $MEDP stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/15, 02/26 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$MEDP Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 5 analysts offer price targets for $MEDP in the last 6 months, with a median target of $484.0.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $547.0 on 07/08/2026
- David Windley from Jefferies set a target price of $515.0 on 07/07/2026
- Ryan Halsted from RBC Capital set a target price of $484.0 on 04/24/2026
- Sean Dodge from BMO Capital set a target price of $400.0 on 04/24/2026
- Luke Sergott from Barclays set a target price of $450.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
